Screener
Rigel Pharmaceuticals RIGL Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Income from operations | 11,885 | 12,773 |
| Interest income | 1,205 | 591 |
| Interest expense | (1,433) | (1,853) |
| Income before income taxes | 11,657 | 11,511 |
| Provision for income taxes | 3,003 | 65 |
| Net income | $8,654 | $11,446 |
| Net income per share | ||
| Basic | $0.47 | $0.64 |
Item 1. Financial Statements
FAQ
- What is Rigel Pharmaceuticals's pre-tax income?
- Rigel Pharmaceuticals (RIGL) reported pre-tax income of $11.66M in Q1 2026.
- How has Rigel Pharmaceuticals's pre-tax income changed year-over-year?
- Rigel Pharmaceuticals's pre-tax income increased by 1.3% year-over-year, from $11.51M to $11.66M.
- What is the long-term trend for Rigel Pharmaceuticals's pre-tax income?
- Over 4 years (2021 to 2025), Rigel Pharmaceuticals's pre-tax income has grown at a 62.9% compound annual growth rate (CAGR), from -$17.31M to $121.83M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Rigel Pharmaceuticals's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude